NCT00795509View on ClinicalTrials.gov

Special Investigation For Long Term Use Of Tolterodine (Regulatory Post Marketing Commitment Plan).

CompletedOBSERVATIONAL
Enrollment

374

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Urinary Bladder, Overactive
Interventions
DRUG

Tolterodine tartrate

"Detrusitol® Capsule 2mg and 4mg, depending on the Investigator prescription. Frequency and duration are according to Package Insert as follows. The usual adult dosage for oral administration is 4 mg of tolterodine tartrate once daily. Occasionally dose reduction might be needed due to individual tolerability."

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00795509 - Special Investigation For Long Term Use Of Tolterodine (Regulatory Post Marketing Commitment Plan). | Biotech Hunter | Biotech Hunter